Status:
UNKNOWN
Bone Mineral Density Changes Among Clinical Subtypes of Parkinson's Disease
Lead Sponsor:
Ordu University
Conditions:
Parkinson Disease
Bone Loss
Eligibility:
All Genders
40-85 years
Brief Summary
The bone loss in Parkinson's disease (PD) emerges as a non-motor symptom with motor and non-motor outcomes, such as fracture and musculoskeletal pain. Bone mineral density (BMD) is decreasing in patie...
Detailed Description
The investigators are planning to complete this study between January and February 2019. This study will be performed at Ordu University Education and Research Hospital, Neurology Department. All pat...
Eligibility Criteria
Inclusion
- For TDT and PIGDT PD group
- Clinical diagnosis of idiopathic Parkinson's disease Age of 40-85 years
Exclusion
- Having additional orthopedic and neurological disorders Having metabolic disease, Having steroid drug use
- For Control group
- The similar age and sex-matched healthy individuals who have no orthopedic, metabolic and neurological disorders, and steroid use will be included in the study.
Key Trial Info
Start Date :
February 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2019
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03806517
Start Date
February 10 2019
End Date
February 28 2019
Last Update
February 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sevim ACARÖZ CANDAN
Ordu, Altinordu, Turkey (Türkiye), 52100